Preventing postpartum smoking relapse among diverse low-income women: A randomized clinical trial
Open accessThe DOI matches its Crossref record; 15 of the 15 references it cites were found in a registry or an index.
Abstract
INTRODUCTION: Postpartum relapse rates are high among women who spontaneously quit smoking during pregnancy. This randomized clinical trial tested a Motivation and Problem-Solving (MAPS) treatment for reducing postpartum relapse among diverse low-income women who quit smoking during pregnancy (N = 251; 32% Black, 30% Latino, and 36% White; 55% <$30,000/year household income). METHODS: Pregnant women were randomly assigned to MAPS/MAPS+ or Usual Care (UC). Continuation ratio logit models were used to examine differences in biochemically confirmed continuous abstinence at Weeks 8 and 26 postpartum by treatment group and moderators of the treatment effect. Analyses controlled for age, race/ethnicity, partner status, education, smoking rate, and the number of smokers in the participant's environment. RESULTS: MAPS/MAPS+ was more efficacious than UC in the prevention of postpartum relapse (p = .05). An interaction between treatment and the number of cigarettes smoked per day before quitting approached significance (p = .09), suggesting that the MAPS/MAPS+ treatment effect was stronger among women who smoked more cigarettes per day. DISCUSSION: MAPS, a holistic and dynamic approach to changing behavior using a combined motivational enhancement and social cognitive approach, is a promising intervention for postpartum smoking relapse prevention among low-income women, which may have particular relevance for women with higher prequit smoking rates.
Overview
The claims and statistics of this paper haven’t been checked yet.
Free: it reads the open-access text and checks the first 5 claims that cite a source we can check. Create a free account to check every claim.
Integrity signals
Registry
Cites
Statistics
Verification
Claims the paper makes
The claims and statistics of this paper haven’t been checked yet.
Free: it reads the open-access text and checks the first 5 claims that cite a source we can check. Create a free account to check every claim.
Self-check
Percentages, sums and reported differences re-computed from the paper’s own numbers.
The self-check needs the paper’s full text.
Citations
Cites
Bellg, A. J., Treatment Fidelity Workgroup of the NIH Behavior Change Consortium, Borrelli, B., Resnick, B., Hecht, J., Minicucci, D. S., Ory, M., Ogedegbe, G., Orwig, D., Ernst, D., et al. (2004) · Health Psychology · doi:10.1037/0278-6133.23.5.443 · Cited by 2,620 · cited 2×
“MAPS/MAPS+ efficacy or effectiveness studies might benefit from the assessment of the specific treatment strategies reviewed with each patient, as well as the participant enactment of treatment skills, as these variables inform treatment fidelity and affect reliability and external validity (Bellg et al., 2004; Borrel…”
BackgroundWhat is Motivational Interviewing?
Rollnick, S., & Miller, W. R. (1995) · Behavioural and Cognitive Psychotherapy · doi:10.1017/s135246580001643x · Cited by 1,737
Ten Things that Motivational Interviewing Is Not
Miller, W. R., & Rollnick, S. (2009) · Behavioural and Cognitive Psychotherapy · doi:10.1017/s1352465809005128 · Cited by 1,315 · cited 1×
“Although MI is not stage-based intervention (Miller & Rollnick, 2009), it has two distinct phases of treatment—building motivation (Phase 1) and strengthening commitment (Phase 2; Miller & Rollnick, 2002).”
BackgroundCnattingius, S. (2004) · Nicotine & Tobacco Research · doi:10.1080/14622200410001669187 · Cited by 1,126 · cited 1×
“(e.g., Cnattingius, 2004; Floyd, Rimer, Giovino, Mullen, & Sullivan, 1993; Roza et al., 2007; Shah, Sullivan, & Carter, 2006), there is a strong need to develop innovative treatments to reduce smoking relapse within this population (Fiore et al., 2008).”
BackgroundRelapse Prevention for Alcohol and Drug Problems: That Was Zen, This Is Tao
Witkiewitz, K., & Marlatt, G. A. (2004) · American Psychologist · doi:10.1037/0003-066x.59.4.224 · Cited by 880
Borrelli, B., Sepinwall, D., Ernst, D., Bellg, A. J., Czajkowski, S., Breger, R., DeFrancesco, C., Levesque, C., Sharp, D. L., Ogedegbe, G., et al. (2005) · Journal of Consulting and Clinical Psychology · doi:10.1037/0022-006x.73.5.852 · Cited by 803
First lapses to smoking: Within-subjects analysis of real-time reports.
Shiffman, S., Paty, J. A., Gnys, M., Kassel, J. A., & Hickcox, M. (1996) · Journal of Consulting and Clinical Psychology · doi:10.1037/0022-006x.64.2.366 · Cited by 745
Negative Affect and Smoking Lapses: A Prospective Analysis.
Shiffman, S., & Waters, A. J. (2004) · Journal of Consulting and Clinical Psychology · doi:10.1037/0022-006x.72.2.192 · Cited by 427 · cited 1×
“Thus, in addition to directly targeting smoking abstinence, MAPS assists women with their various life stressors that may ultimately affect abstinence (Drobes, Meier, & Tiffany, 1994; Shiffman & Waters, 2004; Wetter et al., 1999).”
BackgroundSelf-Efficacy and Addictive Behaviors
DiClemente, C. C., Fairhurst, S. K., & Piotrowski, N. A. (1995) · The Plenum Series in Social/Clinical Psychology · doi:10.1007/978-1-4419-6868-5_4 · Cited by 312
“Catastrophic” pathways to smoking cessation: findings from national survey
West, R., & Sohal, T. (2006) · BMJ · doi:10.1136/bmj.38723.573866.ae · Cited by 287 · cited 1×
“For example, 41% of smokers in the United States report that their motivation to quit smoking changes daily (Werner, Lovering, & Herzog, 2004), and half or more of quit attempts are unplanned (Larabie, 2005; West & Sohal, 2006).”
BackgroundRelapse prevention as a psychosocial treatment: A review of controlled clinical trials.
Carroll, K. M. (1996) · Experimental and Clinical Psychopharmacology · doi:10.1037/1064-1297.4.1.46 · Cited by 285
Intentions to quit smoking change over short periods of time
Hughes, J. R., Keely, J. P., Fagerstrom, K. O., & Callas, P. W. (2005) · Addictive Behaviors · doi:10.1016/j.addbeh.2004.08.011 · Cited by 122 · cited 1×
“As such, MAPS/MAPS+ is responsive to research indicating that motivation for quitting and maintaining abstinence varies over short periods of time (Hughes et al., 2005; Werner et al., 2004) and differs from other interventions that conceptualize motivation as stage based and less volatile (e.g.,…”
Background(2009) · doi:10.1002/14651858.cd003999.pub3 · Cited by 119 · cited 3×
“, 2000) and the limitations of previous interventions (Hajek et al., 2009; Lancaster et al., 2006), the need for innovative and effective interventions to prevent postpartum relapse is paramount (Fiore et al.”
BackgroundPark, E. R., Chang, Y., Quinn, V., Regan, S., Cohen, L., Viguera, A., Psaros, C., Ross, K., & Rigotti, N. (2009) · Nicotine & Tobacco Research · doi:10.1093/ntr/ntp053 · Cited by 102 · cited 1×
“…pregnant/postpartum women might be further enhanced by addressing the myriad of stressors common among such populations, including high levels of stress, negative affect and depression, and low levels of social support (Allen, Prince, & Dietz, 2009; Park et al., 2009; Reitzel et al., 2007).”
BackgroundPostpartum Depressive Symptoms and Smoking Relapse
Allen, A. M., Prince, C. B., & Dietz, P. M. (2009) · American Journal of Preventive Medicine · doi:10.1016/j.amepre.2008.09.020 · Cited by 57
Cited by
Psychosocial interventions for supporting women to stop smoking in pregnancy
Chamberlain, C., O'Mara-Eves, A., Porter, J., Coleman, T., Perlen, S. M., Thomas, J., & McKenzie, J. E. (2017) · Cochrane Database of Systematic Reviews · doi:10.1002/14651858.cd001055.pub5 · Cited by 650
Relapse prevention interventions for smoking cessation
Hajek, P., Stead, L. F., West, R., Jarvis, M., Hartmann-Boyce, J., & Lancaster, T. (2013) · Cochrane Database of Systematic Reviews · doi:10.1002/14651858.cd003999.pub4 · Cited by 467
Hill, S., Amos, A., Clifford, D., & Platt, S. (2014) · Tobacco Control · doi:10.1136/tobaccocontrol-2013-051110 · Cited by 398
Motivational interviewing for smoking cessation
Lindson-Hawley, N., Thompson, T. P., & Begh, R. (2015) · Cochrane Database of Systematic Reviews · doi:10.1002/14651858.cd006936.pub3 · Cited by 386
Substance use during pregnancy
Forray, A. (2016) · F1000Research · doi:10.12688/f1000research.7645.1 · Cited by 311
Metadata
- Authors
- Reitzel, L. R., Vidrine, J. I., Businelle, M. S., Kendzor, D. E., Costello, T. J., Li, Y., Daza, P., Mullen, P. D., Velasquez, M. M., Cinciripini, P. M., Cofta-Woerpel, L., & Wetter, D. W.
- Venue
- Nicotine & Tobacco Research
- Publisher
- Oxford University Press (OUP)
- Published
- 2010-02-12
- Volume
- 12
- Issue
- 4
- Pages
- 326-335
- ISSN
- 1462-2203 (ISSN-L)
- 1469-994X
- OpenAlex
- W1985461421
- Cited by
- 78
- References
- 15
- FWCI
- 4.38
- Type
- journal article
- Language
- en
- Open access
- green
About these checks
Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.
Statistics and arithmetic are recomputed, not judged.
Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.
What counts as a claim ›How we measure confidence ›How we check this ›
Are you an author, or do you see a problem with this page? Request a review
Data sources
Bibliographic data: Semantic Scholar, OpenAlex, Crossref.
Contains information from the Semantic Scholar Academic Graph Datasets, made available under the ODC Attribution License (ODC-BY 1.0).
Semantic Scholar’s data is described in: Kinney, R., et al. (2023). The Semantic Scholar Open Data Platform. arXiv:2301.10140.